iSonea launches into US market with American Depositary Receipts – Proactive Investors Australia


Proactive Investors Australia

iSonea launches into US market with American Depositary Receipts
Proactive Investors Australia
Medical technology company iSonea is focused on developing innovative monitoring systems and software for the management of asthma. The company is currently working on the development and launch of the first Acoustic Respiratory Monitoring devices,
iSonea rights issues provides better than expected return of A$4.6mProactive Investors USA & Canada

all 4 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.